4.4 Article

Symptom dimensions and functional impairment in early psychosis: More to the story than just negative symptoms

期刊

SCHIZOPHRENIA RESEARCH
卷 147, 期 1, 页码 125-131

出版社

ELSEVIER
DOI: 10.1016/j.schres.2013.03.024

关键词

Schizophrenia; Clinical high risk; Recent onset psychosis; Psychosocial functioning; Negative symptoms; Depression

资金

  1. National Institutes of Mental Health [2T32 MH018261-27, 1K23MH087708-01A1, 5R01MH059883, R01MH076989]
  2. Brain and Behavior Research Fund
  3. GlaxoSmithKline
  4. Brain Plasticity Institute
  5. Amgen
  6. Hoffman La Roche
  7. Genentech

向作者/读者索取更多资源

Functional impairment is a defining feature of psychotic disorders and usually appears well before their onset. Negative symptoms play a prominent role in the impaired functioning of individuals with schizophrenia and those at clinical-high-risk (CHR) for psychosis. Despite high rates of depression and anxiety in early psychosis, few studies have examined the contribution of these symptoms to functioning in the putative 'prodrome.' In the current study, we tested the hypotheses that 1) worse negative and disorganized, but not positive, symptoms would be significantly related to impaired social and role functioning in two cohorts of CHR individuals (combined N = 98) and a separate sample of individuals with recent-onset (RO) psychotic disorders (N = 88); and 2) worse anxiety and depression would be significantly related to impaired functioning in both samples, above and beyond the contributions of negative and disorganized symptoms. Findings largely supported our hypotheses that more severe negative and disorganized symptoms were related to poorer social and role functioning in both samples. Anxiety and depression severity were significantly related to poorer functioning in both samples. In addition, depression, but not anxiety, predicted poorer global and social functioning above and beyond that explained by negative symptoms in the CHR sample. These results suggest the need for phase-specific treatment in early psychosis, with a focus on symptom dimensions to improve functional outcomes for CHR individuals. (C) 2013 Elsevier B. V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据